Vistagen Therapeutics, Inc. (VTGN)
NASDAQ: VTGN · Real-Time Price · USD
0.6090
-0.0333 (-5.18%)
At close: Mar 20, 2026, 4:00 PM EDT
0.6089
-0.0001 (-0.02%)
After-hours: Mar 20, 2026, 7:10 PM EDT
Vistagen Therapeutics Market Cap
Vistagen Therapeutics has a market cap or net worth of $24.13 million as of March 20, 2026. Its market cap has decreased by -68.70% in one year.
Market Cap
24.13M
Enterprise Value
-36.21M
1-Year Change
-68.70%
Ranking
Category
Stock Price
$0.61
Market Cap Chart
Since May 11, 2016, Vistagen Therapeutics's market cap has increased from $9.30M to $24.13M, an increase of 159.45%. That is a compound annual growth rate of 10.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 20, 2026 | 24.10M | -7.66% |
| Dec 31, 2025 | 26.10M | -68.21% |
| Dec 31, 2024 | 82.10M | -40.89% |
| Dec 29, 2023 | 138.90M | 552.11% |
| Dec 30, 2022 | 21.30M | -94.53% |
| Dec 31, 2021 | 389.40M | 171.17% |
| Dec 31, 2020 | 143.60M | 381.88% |
| Dec 31, 2019 | 29.80M | -36.05% |
| Dec 31, 2018 | 46.60M | 258.46% |
| Dec 29, 2017 | 13.00M | -58.47% |
| Dec 30, 2016 | 31.30M | 236.56% |
| May 11, 2016 | 9.30M | - |
View and export this data all the way back to 2016. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cue Biopharma | 25.96M |
| Barinthus Biotherapeutics | 25.73M |
| NeuroSense Therapeutics | 25.15M |
| Neuphoria Therapeutics | 24.85M |
| Enlivex | 24.34M |
| Senti Biosciences | 24.19M |
| Passage Bio | 23.83M |
| Lantern Pharma | 23.82M |